GB202207246D0 - PCSK9 antagonist - Google Patents
PCSK9 antagonistInfo
- Publication number
- GB202207246D0 GB202207246D0 GBGB2207246.6A GB202207246A GB202207246D0 GB 202207246 D0 GB202207246 D0 GB 202207246D0 GB 202207246 A GB202207246 A GB 202207246A GB 202207246 D0 GB202207246 D0 GB 202207246D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- pcsk9 antagonist
- pcsk9
- antagonist
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 101001098868 Homo sapiens Proprotein convertase subtilisin/kexin type 9 Proteins 0.000 title 1
- 102100038955 Proprotein convertase subtilisin/kexin type 9 Human genes 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2207246.6A GB202207246D0 (en) | 2022-05-18 | 2022-05-18 | PCSK9 antagonist |
GB2306581.6A GB2618915A (en) | 2022-05-18 | 2023-05-04 | Treatment of cardiovascular disease |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2207246.6A GB202207246D0 (en) | 2022-05-18 | 2022-05-18 | PCSK9 antagonist |
Publications (1)
Publication Number | Publication Date |
---|---|
GB202207246D0 true GB202207246D0 (en) | 2022-06-29 |
Family
ID=82155981
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB2207246.6A Ceased GB202207246D0 (en) | 2022-05-18 | 2022-05-18 | PCSK9 antagonist |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB202207246D0 (en) |
-
2022
- 2022-05-18 GB GBGB2207246.6A patent/GB202207246D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL279363A (en) | Pcsk9 antagonist compounds | |
GB2594788B (en) | Antagonist of PCSK9 | |
IL304534A (en) | Kras g12c inhibitors | |
EP3810129A4 (en) | Pcsk9 antagonist bicyclo-compounds | |
EP4076492A4 (en) | Pcsk9 antagonist compounds | |
GB2585278B (en) | Apolipoprotein B Antagonist | |
IL300211A (en) | Antagonist compounds | |
CA199777S (en) | Bowl | |
GB202019622D0 (en) | Antagonist compounds | |
CA198610S (en) | Bowl | |
GB202207246D0 (en) | PCSK9 antagonist | |
EP4317153A4 (en) | Abhd6 antagonist | |
GB202010276D0 (en) | PCSK9 antagonist | |
GB202113104D0 (en) | Antagonist of pcsk9 | |
GB202020553D0 (en) | Antagonist of pcsk9 | |
GB202013998D0 (en) | Antagonist of pcsk9 | |
GB202003756D0 (en) | Antagonist of PCSK9 | |
GB202000906D0 (en) | Antagonist | |
GB202217505D0 (en) | Selective beta2-adrencoceptor antagonist | |
GB202201151D0 (en) | Antagonist compounds | |
CA219625S (en) | Bowl | |
CA216344S (en) | Bowl | |
CA216346S (en) | Bowl | |
CA216355S (en) | Bowl | |
CA198153S (en) | Bowl |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |